Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice

Psychopharmacology

Volumn 217, Issue 4, 2011, Pages 539-548

  Walker, Ellen A ^a   Foley, John J ^a   Clark Vetri, Rachel ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

5 Fluorouracil; Acquisition; Autoshaping; Chemotherapy; Methotrexate; Mice; Retention; Tamoxifen

Indexed keywords

FLUOROURACIL; METHOTREXATE; SODIUM CHLORIDE; TAMOXIFEN CITRATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSHAPING; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EXPOSURE; LATENT PERIOD; LEARNING; MALE; MEMORY; MENTAL FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPEATED DRUG DOSE; RESPONSE TIME; STIMULUS RESPONSE; TREATMENT DURATION; VULNERABLE POPULATION; WEIGHT REDUCTION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BEHAVIOR, ANIMAL; BODY WEIGHT; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; LEARNING; MALE; MEMORY; METHOTREXATE; MICE; MICE, INBRED STRAINS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 82955233935     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2310-8     Document Type: Article

References (55)

1. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192-201
2. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493 (Pubitemid 34072533)
3. Barrett JE, Vanover KE (2003) Assessment of learning and memory using the autoshaping of operant responding in mice. Curr Protoc Neurosci 8:8.5 F.1-8.5 F.8
4. Bender CM (2006) Chemotherapy may have small to moderate negative effects on cognitive functioning. Cancer Treat Rev 32:316-319
5. Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL (2001) Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. J Pain Symptom Manage 21:407-424 (Pubitemid 32452141)
6. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422-430 (Pubitemid 43826855)
7. Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, Cohen SM, Casillo FE, Berga SL (2007) Memory impairments with adjuvant anastrozole versus tamoxifen in women with earlystage breast cancer. Menopause 14:995-998 (Pubitemid 350098658)
8. Bonadonna G, Moliterni A, Zambetti M, Daidone MG, Pilotti S, Gianni L, Valagussa P (2005) 30 years' follow up of randomised studies of adjuvantCMF in operable breast cancer: cohort study.BMJ 330:217
9. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-2701 (Pubitemid 30463551)
10. Buddaraaju AKV, Van Dyke RW (2003) Effects of animal bedding on rat liver endosome acidification. Comparative Medicine, AALAS 53(6):616-621 (Pubitemid 38084330)
11. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969 (Pubitemid 39577316)
12. Chen D, Wu CF, Shi B, Xu YM (2002a) Tamoxifen and toremifene cause impairment of learning and memory function in mice. Pharmacol Biochem Behav 71:269-276
13. Chen D, Wu CF, Shi B, Xu YM (2002b) Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice. Pharmacol Biochem Behav 72:417-421 (Pubitemid 34251353)
14. Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5:22.1-22.23
15. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB (2005) Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104:2499-2507 (Pubitemid 41691574)
16. ElBeltagy M, Mustafa S, Umka J, Lyons L, Salman A, Chur-yoe GT, Bhalla N, Bennett G, Wigmore PM (2010) Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behav Brain Res 208:112-117
17. Esmaeili B, Basseda Z, Gholizadeh S, Javadi Paydar M, Dehpour AR (2009) Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol. Psychopharmacology (Berl) 204:191-201
18. Foley JJ, Raffa RB, Walker EA (2008) Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) 199:527-538
19. Gandal MJ, Ehrlichman RS, Rudnick ND, Siegel SJ (2008) A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience 157:95-104
20. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Proschel M, Noble M (2008) Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 7:12
21. Harasym TO, Tardi PG, Harasym NL, Harvie P, Johnstone SA, Mayer LD (2007) Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratios. Oncol Res 16:361-374 (Pubitemid 47413252)
22. Institute of Laboratory Animal Resources (2003) Guidelines for the care and use of mammals in neuroscience and behavioral research. National Academies, Washington, DC
23. Janelsins MC, Roscoe JA, Berg MJ, Thompson BD, Gallagher MJ, Morrow GR, Heckler CE, Jean-Pierre P, Opanashuk LA, Gross RA (2010) IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest 28(5):544-553
24. Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL (2005) Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 96:48-53 (Pubitemid 40942867)
25. Jones KL, Buzdar AU (2004) A review of adjuvant hormonal therapy in breast cancer. Endocr Relat Cancer 11:391-406 (Pubitemid 39334838)
26. Jurcovicova J, Svik K, Scsukova S, Bauerova K, Rovensky J, Stancikova M (2009) Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis. Rheumatol Int 29(10):1187-1191
27. Kisanga ER, Gjerde J, Schjott J, Mellgren G, Lien EA (2003) Tamoxifen administration and metabolism in nude mice and nude rats. J Steroid Biochem Mol Biol 84:361-367 (Pubitemid 36514852)
28. Kisanga ER, Gjerde J, Guerrieri-Gonzaga A, Pigatto F, Pesci-Feltri A, Robertson C, Serrano D, Pelosi G, Decensi A, Lien EA (2004) Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin Cancer Res 10:2336-2343 (Pubitemid 38445691)
29. Le Bricon T, Gugins S, Cynober L, Baracos VE (1995) Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats. Metabolism 44(10):1340-1348 (Pubitemid 26087798)
30. Lee GD, Longo DL, Wang Y, Rifkind JM, Abdul-Raman L, Mamczarz JA, Duffy KB, Spangler EL, Taub DD, Mattson MP, Ingram DK (2006) Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy. Clin Cancer Res 12:198-205 (Pubitemid 43166195)
31. López M, Lelliott CJ, Tovar S, Kimber W, Gallego R, Virtue S, Blount M, Vázquez MJ, Finer N, Powles TJ, O'Rahilly S, Saha AK, Diéguez C, Vidal-Puig AJ (2006) Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55(5):1327-1336 (Pubitemid 44195371)
32. Madhyastha S, Somayaji SN, Rao MS, Nalini K, Bairy KL (2002) Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol 80:1076-1084 (Pubitemid 36002665)
33. Mayer LD, Janoff AS (2007) Optimizing combination chemotherapy by controlling drug ratios. Mol Interv 7:216-223 (Pubitemid 47437268)
34. Mayer LD, Harasym TO, Tardi PG, Harasym NL, Shew CR, Johnstone SA, Ramsay EC, Bally MB, Janoff AS (2006) Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Mol Cancer Ther 5:1854-1863 (Pubitemid 44323254)
35. Mignone RG, Weber ET (2006) Potent inhibition of cell proliferation in the hippocampal dentate gyrus of mice by the chemotherapeutic drug thioTEPA. Brain Res 1111:26-29 (Pubitemid 44331189)
36. Raffa RB, Duong PV, Finney J, Garber DA, Lam LM, Mathew SS, Patel NN, Plaskett KC, Shah M, Jen Weng HF (2006) Is 'chemofog'/' chemo-brain' caused by cancer chemotherapy? J Clin Pharm Ther 31:129-138
37. Reiriz AB, Reolon GK, Preissler T, Rosado JO, Henriques JA, Roesler R, Schwartsmann G (2006) Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res 12:5000, author reply 5000-1
38. Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC (1991) Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 19:36-43
39. Saykin AJ, Wishart HA (2003) Mild cognitive impairment: conceptual issues and structural and functional brain correlates. Semin Clin Neuropsychiatry 8:12-30 (Pubitemid 36828248)
40. Saykin AJ, Ahles TA, McDonald BC (2003) Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8:201-216 (Pubitemid 37474731)
41. Schagen SB, van Dam FS (2006) Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect? J Clin Oncol 24:5170-5171, author reply 5171-2
42. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650 (Pubitemid 29075285)
43. Schilder CM, Schagen SB (2007) Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature. Minerva Ginecol 59:387-401 (Pubitemid 350155486)
44. Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, Van Dam FS, Schagen SB (2009) Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol 48:76-85
45. Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, Huizenga HM, Nortier JW, van de Velde CJ, van Dam FS, Schagen SB (2010) Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 28:1294-1300
46. Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, Koolhaas JM, Buwalda B (2008) Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 186:168-175 (Pubitemid 350122748)
47. Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvanttreated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 103:303-311 (Pubitemid 46944511)
48. Sinno MH, Coquerel Q, Boukhettala N, Coëffier M, Gallas S, Terashi M, Ibrahim A, Breuillé D, Déchelotte P, Fetissov SO (2010) Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration. Physiol Behav 101 (5):639-648
49. Stock HS, Rosellini RA, Abrahamsen GC, McCaffrey RJ, Ruckdeschel JC (1995) Methotrexate does not interfere with an appetitive Pavlovian conditioning task in Sprague-Dawley rats. Physiol Behav 58:969-973
50. Takeda N, Hasegawa S, Morita M, Matsunaga T (1993) Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav 45(4):817-821
51. Vanover KE, Barrett JE (1998) An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response. Behav Pharmacol 9:273-283 (Pubitemid 28273113)
52. Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455-2463 (Pubitemid 46999217)
53. Walker EA (2010) Animal models. Adv Exp Med Biol 678:138-146
54. Winocur G, Vardy J, Binns MA, Kerr L, Tannock I (2006) The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 85:66-75 (Pubitemid 44802737)
55. Yamamoto K, Nakai M, Nohara K, Yamatodani A (2007) The anticancer drug-induced pica in rats is related to their clinical emetogenic potential. Eur J Pharmacol 554(1):34-39 (Pubitemid 44820045)